Replies to post #4767 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

…can [Morgan Stanley] really believe sales of filler and Daxxify are linked in terms of percentage of the market?

No, of course not. It’s a disingenuous rationale to lower the modeled market-share target for Daxxify.